Richmond's Phlow closes $36M Series B round
April 19, 2023 at 14:33 PM EDT
The public benefit corporation seeks to manufacture high-quality, essential generic drugs at a low cost.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
